10 Best Undervalued Smallmid Cap Moat Stocks for October 2025
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Market Overview & Selection Criteria
The current market environment is characterized by heightened volatility and sector rotation, with investors seeking resilient growth and value opportunities. Our selection methodology leverages ValueSense’s proprietary intrinsic value models, quality ratings, and financial health metrics to identify stocks with strong fundamentals, attractive valuations, and sectoral diversification. Each pick is screened for robust free cash flow, sustainable margins, and reasonable debt levels, ensuring a balanced portfolio of technology, healthcare, industrials, and commodities.
Featured Stock Analysis
Pegasystems Inc. (PEGA)
| Metric | Value |
|---|---|
| Market Cap | $9,322.7M |
| Quality Rating | 7.0 |
| Intrinsic Value | $88.6 |
| 1Y Return | -25.5% |
| Revenue | $1,676.0M |
| Free Cash Flow | $410.3M |
| Revenue Growth | 12.5% |
| FCF margin | 24.5% |
| Gross margin | 75.5% |
| ROIC | 35.2% |
| Total Debt to Equity | 12.7% |
Investment Thesis
Pegasystems Inc. stands out in the technology sector for its robust software solutions and consistent revenue growth. Despite a challenging year with a -25.5% return, PEGA’s fundamentals remain strong, highlighted by a 12.5% revenue growth and a substantial free cash flow margin of 24.5%. The company’s intrinsic value of $88.6 suggests significant upside potential compared to current market levels. With a quality rating of 7.0 and a market cap of $9.3B, PEGA demonstrates operational efficiency, evidenced by a 75.5% gross margin and a 35.2% ROIC.
Key Catalysts
- Expansion of enterprise software offerings
- High gross margin 75.5% supporting profitability
- Strong free cash flow generation $410.3M
- Low total debt to equity 12.7% indicating financial stability
Risk Factors
- Recent negative 1-year return -25.5%
- Competitive pressures in enterprise software
- Sensitivity to IT spending cycles
Grupo Aeroportuario del Sureste, S. A. B. de C. V. (ASR)
| Metric | Value |
|---|---|
| Market Cap | $9,111.9M |
| Quality Rating | 7.2 |
| Intrinsic Value | $504.8 |
| 1Y Return | 8.5% |
| Revenue | MX$34.0B |
| Free Cash Flow | MX$9,285.8M |
| Revenue Growth | 21.3% |
| FCF margin | 27.3% |
| Gross margin | 72.5% |
| ROIC | 21.8% |
| Total Debt to Equity | 24.0% |
Investment Thesis
ASR is a leading airport operator in Latin America, benefiting from post-pandemic travel recovery and infrastructure investments. The company posted a solid 8.5% 1-year return and boasts a quality rating of 7.2. With revenue growth at 21.3% and a free cash flow margin of 27.3%, ASR’s financials reflect operational excellence. Its intrinsic value of $504.8 signals potential undervaluation, while a market cap of $9.1B and a gross margin of 72.5% reinforce its competitive position.
Key Catalysts
- Strong travel demand recovery
- High FCF margin 27.3% and robust cash generation
- Infrastructure expansion projects
- Attractive ROIC 21.8%
Risk Factors
- Exposure to macroeconomic and travel industry cycles
- Moderate total debt to equity 24.0%
- Currency risk due to MXN-denominated revenues
New Oriental Education & Technology Group Inc. (EDU)
| Metric | Value |
|---|---|
| Market Cap | $8,805.4M |
| Quality Rating | 5.9 |
| Intrinsic Value | $132.7 |
| 1Y Return | -20.4% |
| Revenue | $4,900.3M |
| Free Cash Flow | $844.1M |
| Revenue Growth | 13.6% |
| FCF margin | 17.2% |
| Gross margin | 55.4% |
| ROIC | 17.2% |
| Total Debt to Equity | 20.3% |
Investment Thesis
EDU is a prominent player in China’s education sector, offering diversified learning solutions. Despite a -20.4% 1-year return, the company maintains solid fundamentals, with 13.6% revenue growth and a 17.2% free cash flow margin. Its intrinsic value of $132.7 and a market cap of $8.8B highlight its scale. EDU’s gross margin of 55.4% and ROIC of 17.2% indicate efficient operations, though regulatory risks remain a concern.
Key Catalysts
- Expansion into online and hybrid education models
- Consistent revenue growth 13.6%
- Strong free cash flow $844.1M
- Large addressable market in China
Risk Factors
- Regulatory uncertainty in China’s education sector
- Moderate total debt to equity 20.3%
- Recent negative stock performance
APA Corporation (APA)
| Metric | Value |
|---|---|
| Market Cap | $8,326.0M |
| Quality Rating | 6.6 |
| Intrinsic Value | $46.2 |
| 1Y Return | -5.3% |
| Revenue | $10.1B |
| Free Cash Flow | $1,634.0M |
| Revenue Growth | 12.1% |
| FCF margin | 16.2% |
| Gross margin | 55.1% |
| ROIC | 22.9% |
| Total Debt to Equity | 67.6% |
Investment Thesis
APA Corporation is a diversified energy company with a focus on oil and gas exploration. Despite a -5.3% 1-year return, APA’s fundamentals are supported by $10.1B in revenue and a 12.1% revenue growth rate. The company’s intrinsic value of $46.2 and market cap of $8.3B suggest room for appreciation. APA’s ROIC of 22.9% and gross margin of 55.1% reflect operational strength, though its total debt to equity ratio 67.6% warrants monitoring.
Key Catalysts
- Rising energy prices and global demand
- Strong free cash flow $1,634.0M
- Attractive ROIC 22.9%
- Strategic asset portfolio
Risk Factors
- High debt levels (67.6% total debt to equity)
- Commodity price volatility
- Environmental and regulatory risks
Corcept Therapeutics Incorporated (CORT)
| Metric | Value |
|---|---|
| Market Cap | $8,273.7M |
| Quality Rating | 6.8 |
| Intrinsic Value | $99.3 |
| 1Y Return | 68.1% |
| Revenue | $716.1M |
| Free Cash Flow | $180.3M |
| Revenue Growth | 25.7% |
| FCF margin | 25.2% |
| Gross margin | 98.4% |
| ROIC | 187.7% |
| Total Debt to Equity | 1.0% |
Investment Thesis
Corcept Therapeutics is a biotech company specializing in treatments for metabolic and psychiatric disorders. CORT delivered an impressive 68.1% 1-year return, driven by 25.7% revenue growth and a remarkable 98.4% gross margin. Its intrinsic value of $99.3 and market cap of $8.3B underscore its growth trajectory. The company’s ROIC of 187.7% and minimal debt (1.0% total debt to equity) highlight exceptional capital efficiency.
Key Catalysts
- Breakthrough therapies with high gross margin 98.4%
- Rapid revenue growth 25.7%
- Minimal leverage (1.0% debt to equity)
- Strong free cash flow $180.3M
Risk Factors
- Clinical and regulatory risks
- Product concentration risk
- Market adoption challenges
Paylocity Holding Corporation (PCTY)
| Metric | Value |
|---|---|
| Market Cap | $8,217.5M |
| Quality Rating | 6.8 |
| Intrinsic Value | $178.0 |
| 1Y Return | -13.3% |
| Revenue | $1,595.2M |
| Free Cash Flow | $324.0M |
| Revenue Growth | 13.7% |
| FCF margin | 20.3% |
| Gross margin | 68.8% |
| ROIC | 32.2% |
| Total Debt to Equity | 17.7% |
Investment Thesis
Paylocity is a cloud-based payroll and HR solutions provider, serving mid-sized businesses. Despite a -13.3% 1-year return, PCTY’s fundamentals are solid, with 13.7% revenue growth and a 20.3% free cash flow margin. Its intrinsic value of $178.0 and market cap of $8.2B reflect growth potential. The company’s gross margin of 68.8% and ROIC of 32.2% support its competitive positioning.
Key Catalysts
- Expansion in cloud HR solutions
- Consistent revenue growth 13.7%
- Strong free cash flow $324.0M
- High gross margin 68.8%
Risk Factors
- Competitive HR tech landscape
- Moderate total debt to equity 17.7%
- Sensitivity to SMB market cycles
Match Group, Inc. (MTCH)
| Metric | Value |
|---|---|
| Market Cap | $7,905.4M |
| Quality Rating | 6.3 |
| Intrinsic Value | $65.7 |
| 1Y Return | -14.0% |
| Revenue | $3,450.6M |
| Free Cash Flow | $907.6M |
| Revenue Growth | (0.6%) |
| FCF margin | 26.3% |
| Gross margin | 71.1% |
| ROIC | 29.6% |
| Total Debt to Equity | (1,485.7%) |
Investment Thesis
Match Group is a global leader in online dating platforms, including Tinder and Hinge. Despite a -14.0% 1-year return and flat revenue growth, MTCH maintains a strong free cash flow margin 26.3% and a gross margin of 71.1%. Its intrinsic value of $65.7 and market cap of $7.9B indicate potential for recovery, supported by a quality rating of 6.3.
Key Catalysts
- Dominant market share in online dating
- High gross margin 71.1%
- Strong free cash flow $907.6M
- Expansion into new markets
Risk Factors
- Negative revenue growth -0.6%
- Extremely high negative debt to equity -1,485.7%
- Competitive pressures and regulatory scrutiny
Dropbox, Inc. (DBX)
| Metric | Value |
|---|---|
| Market Cap | $7,730.7M |
| Quality Rating | 6.8 |
| Intrinsic Value | $62.3 |
| 1Y Return | 8.6% |
| Revenue | $2,532.8M |
| Free Cash Flow | $892.8M |
| Revenue Growth | (0.0%) |
| FCF margin | 35.2% |
| Gross margin | 81.3% |
| ROIC | 59.5% |
| Total Debt to Equity | (233.1%) |
Investment Thesis
Dropbox is a leading cloud storage and collaboration platform. DBX posted an 8.6% 1-year return, with stable revenue and a high free cash flow margin 35.2%. Its intrinsic value of $62.3 and market cap of $7.7B highlight its scale. The company’s gross margin of 81.3% and ROIC of 59.5% reflect operational efficiency, though its negative debt to equity -233.1% is notable.
Key Catalysts
- Expansion of cloud collaboration tools
- High gross margin 81.3%
- Strong free cash flow $892.8M
- Stable revenue base
Risk Factors
- Flat revenue growth 0.0%
- High negative debt to equity -233.1%
- Intense competition in cloud services
H&R Block, Inc. (HRB)
| Metric | Value |
|---|---|
| Market Cap | $6,875.5M |
| Quality Rating | 6.4 |
| Intrinsic Value | $99.1 |
| 1Y Return | -15.1% |
| Revenue | $3,761.0M |
| Free Cash Flow | $598.8M |
| Revenue Growth | 4.2% |
| FCF margin | 15.9% |
| Gross margin | 44.5% |
| ROIC | 39.0% |
| Total Debt to Equity | 2,278.2% |
Investment Thesis
H&R Block is a leading provider of tax preparation services. Despite a -15.1% 1-year return, HRB’s fundamentals include a 4.2% revenue growth and a 15.9% free cash flow margin. Its intrinsic value of $99.1 and market cap of $6.9B suggest potential upside. The company’s gross margin of 44.5% and ROIC of 39.0% indicate operational resilience, though its high total debt to equity 2,278.2% is a concern.
Key Catalysts
- Stable demand for tax services
- Consistent free cash flow $598.8M
- High ROIC 39.0%
- Brand recognition
Risk Factors
- High leverage (2,278.2% debt to equity)
- Seasonal business model
- Regulatory changes
Allison Transmission Holdings, Inc. (ALSN)
| Metric | Value |
|---|---|
| Market Cap | $6,865.3M |
| Quality Rating | 7.4 |
| Intrinsic Value | $98.4 |
| 1Y Return | -17.5% |
| Revenue | $3,200.0M |
| Free Cash Flow | $786.0M |
| Revenue Growth | 2.7% |
| FCF margin | 24.6% |
| Gross margin | 48.4% |
| ROIC | 19.8% |
| Total Debt to Equity | 137.9% |
Investment Thesis
Allison Transmission is a global leader in commercial-duty automatic transmissions. Despite a -17.5% 1-year return, ALSN’s fundamentals are robust, with a quality rating of 7.4—the highest in this collection. Its intrinsic value of $98.4 and market cap of $6.9B highlight its value proposition. The company’s 2.7% revenue growth, 24.6% free cash flow margin, and 48.4% gross margin support its long-term outlook.
Key Catalysts
- Leadership in commercial transmission technology
- High free cash flow margin 24.6%
- Strong quality rating 7.4
- Attractive ROIC 19.8%
Risk Factors
- Moderate revenue growth 2.7%
- High total debt to equity 137.9%
- Cyclical demand in commercial vehicles
Portfolio Diversification Insights
This watchlist spans technology (PEGA, DBX, PCTY), healthcare/biotech (CORT), education (EDU), energy/commodities (APA, ALSN), consumer services (HRB, MTCH), and infrastructure (ASR). The sector allocation balances growth and defensive themes, with exposure to both cyclical and non-cyclical industries. High-quality ratings and varied debt profiles help mitigate single-stock risk, while the mix of international and domestic companies enhances geographic diversification.
Market Timing & Entry Strategies
Given recent market volatility, staggered entry strategies such as dollar-cost averaging can help manage risk. Monitoring sector rotation and macroeconomic indicators is crucial; for example, energy and infrastructure stocks may benefit from inflationary trends, while technology and healthcare could outperform in periods of economic stability. Investors should consider technical support levels and earnings calendars when timing entries.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2025)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!
More Articles You Might Like
- 10 Best Smallmid Cap Moat Stocks for October 2025
- 10 Best Undervalued Large Cap Moat Stocks for October 2025
- 10 Best Large Cap Moat Stocks for October 2025
- 10 Best Technology Moat Stocks for October 2025
- 10 Best Industrials Moat Stocks for October 2025
FAQ Section
Q1: How were these stocks selected?
Stocks were chosen using ValueSense’s intrinsic value models, quality ratings, and financial health metrics, focusing on undervalued companies with strong fundamentals and sector diversification.
Q2: What's the best stock from this list?
Each stock offers unique strengths; for example, Corcept Therapeutics (CORT) posted the highest 1-year return and ROIC, while Allison Transmission (ALSN) holds the highest quality rating. The “best” depends on individual investment goals and risk tolerance.
Q3: Should I buy all these stocks or diversify?
Diversification across sectors and risk profiles is recommended for educational purposes. This watchlist is structured to provide balanced exposure rather than concentrated bets.
Q4: What are the biggest risks with these picks?
Risks include sector-specific challenges (regulatory, competitive, macroeconomic), high leverage in some companies, and recent negative returns for several stocks. Always review individual risk factors.
Q5: When is the best time to invest in these stocks?
Market timing depends on sector trends, earnings releases, and macroeconomic conditions. Staggered entry and monitoring technical levels can help manage volatility.